Screening for ELANE, HAX1 and GFI1 gene mutations in children with neutropenia and clinical characterization of two novel mutations in ELANE gene

被引:1
|
作者
Komvilaisak, Patcharee [1 ]
Yudhasompop, Najwa [2 ]
Kanchanakamhaeng, Kittima [3 ]
Hongeng, Suradej [4 ]
Pakakasama, Samart [4 ]
Anurathapan, Usanarat [4 ]
Pongphitcha, Pongpak [4 ]
Songdej, Duantida [4 ]
Sasanakul, Werasak [4 ]
Sirachainan, Nongnuch [4 ]
机构
[1] Khon Kaen Univ, Fac Med, Dept Pediat, Khon Kaen, Thailand
[2] Hatyai Hosp, Dept Radiol, Songkhla, Thailand
[3] Sawanpracharak Hosp, Dept Pediat, Nakhon Sawan, Thailand
[4] Mahidol Univ, Ramathibodi Hosp, Dept Pediat, Fac Med, 270 Rama VI Rd, Bangkok 10400, Thailand
关键词
Severe congenital neutropenia; Cyclic neutropenia; ELANE Gene; SEVERE CONGENITAL NEUTROPENIA; MYELOID-LEUKEMIA; DIAGNOSIS; ELASTASE;
D O I
10.1186/s12887-023-04428-w
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background Congenital neutropenia is a rare disease. Recurrent infections since young age are the presentation. The most common mutation causing severe congenital neutropenia (SCN) and cyclic neutropenia (CyN) is the ELANE gene. The objectives of this study were to screen the three common genetic mutations of ELANE, HAX1 and GFI1 in children with chronic neutropenia and to describe the clinical characteristics of children who had the mutations. Methods Infants having ANC < 1,000/cu mm or children aged > 1 year having ANC < 1,500/cu mm at least 3 times in 3 months were enrolled in the study. Patients who had acquired neutropenia due to infection, immune deficiency, or drugs were excluded. The ELANE gene was first studied; and if mutations were not identified, the HAX1 and GFI1 genes were further examined. Results A total of 60 patients were enrolled in the study. The median (range) age, ratio of female to male, ANC, and last follow-up age were 9.2 (0.5-45.2) months, 1:1.2, 248 (0-1,101) /cu mm, and 19.9 (3.5-202.3) months, respectively. Infections were noted in 67.3% of all patients. ELANE gene mutation was found in only four patients (6.7%), and the rest (56 patients) showed no mutations in the HAX1 and GFI1 genes. In patients without mutations, 66.0% had normal ANC during the follow-up, with a median (range) age for normal ANC of 19.8 (4.0-60.0) months. Two novel mutations p. Ala79del (c.234_236del) and p. Val197GlufsTer18 (c.589_590insAGGCCGGC) were identified, and they respectively cause SCN and CyN. Patients with the two novel mutations presented with several episodes of infection, including pneumonia, sepsis, abscess, otitis media, and gum infection. Conclusion The genetic screening for ELANE, HAX1, and GFI1 gene mutations in 60 patients with chronic neutropenia could identify four patients (6.7%) with ELANE gene mutation and two novel mutations, p. Ala79del in exon 3 and p. Val197GlufsTer18 in exon 4 causing SCN; and CyN, respectively.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Two novel mutations in the keratin 1 gene in epidermolytic hyperkeratosis
    Lee, D
    Ahn, K
    Lee, C
    Rho, N
    Lee, J
    Lee, E
    Steinert, P
    Yang, J
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 119 (01) : 269 - 269
  • [42] In vitro study of HAX1 gene therapy by retro viral transduction as a therapeutic target in severe congenital neutropenia
    Farajifard, Hamid
    Zavvar, Mahdi
    Rajaei, Taraneh
    Noorbakhsh, Farshid
    Nikougoftar-zarif, Mahin
    Azadmanesh, Kayhan
    Kompani, Farzad
    Rezaei, Nima
    EUROPEAN CYTOKINE NETWORK, 2018, 29 (04) : 146 - 152
  • [43] In vitro study of HAX1 gene therapy by retro viral transduction as a therapeutic target in severe congenital neutropenia
    Hamid Farajifard
    Mahdi Zavvar
    Taraneh Rajaei
    Farshid Noorbakhsh
    Mahin Nikougoftar-zarif
    Kayhan Azadmanesh
    Farzad Kompani
    Nima Rezaei
    European Cytokine Network, 2018, 29 : 146 - 152
  • [44] Gene mutations in Wilson disease in Egyptian children: Report on two novel mutations
    El-Mougy, Fatma A.
    Sharaf, Sahar A. A.
    Elsharkawy, Marwa M.
    Mandour, Iman A.
    El-Essawy, Riham A.
    Eldin, Abeer M.
    Helmy, Heba M.
    Soliman, Dina H.
    Selim, Lamia H.
    Sharafeldin, Heba M.
    Mogahed, Engy A.
    El-Karaksy, Hanaa M.
    ARAB JOURNAL OF GASTROENTEROLOGY, 2014, 15 (3-4) : 114 - 118
  • [45] Clinical and molecular genetic characterization of two patients with mutations in the phosphoglucomutase 1 (PGM1) gene
    Ding, Yu
    Li, Niu
    Chang, Gouying
    Li, Juan
    Yao, Ruen
    Shen, Yiping
    Wang, Jian
    Huang, Xiaodong
    Wang, Xiumin
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2018, 31 (07): : 781 - 788
  • [46] Neurodevelopmental abnormalities associated with severe congenital neutropenia due to the R86X mutation in the HAX1 gene
    Ishikawa, N.
    Okada, S.
    Miki, M.
    Shirao, K.
    Kihara, H.
    Tsumura, M.
    Nakamura, K.
    Kawaguchi, H.
    Ohtsubo, M.
    Yasunaga, S.
    Matsubara, K.
    Sako, M.
    Hara, J.
    Shiohara, M.
    Kojima, S.
    Sato, T.
    Takihara, Y.
    Kobayashi, M.
    JOURNAL OF MEDICAL GENETICS, 2008, 45 (12) : 802 - 807
  • [47] Neutropenia-associated mutations of PFAAP5, a novel protein mediating transcriptional repressor interaction between Gfi1 and neutrophil elastase.
    Salipante, Stephen J.
    Benson, Kathleen F.
    Person, Richard E.
    Badolato, Raffaele
    Horwitz, Marshall S.
    BLOOD, 2006, 108 (11) : 152A - 152A
  • [48] CHARACTERIZATION OF MUTATIONS IN THE RB1 GENE
    DUNN, JM
    ZHU, X
    GALLIE, BL
    PHILLIPS, RA
    RECESSIVE ONCOGENES AND TUMOR SUPPRESSION, 1989, : 93 - 100
  • [49] Legius Syndrome: two novel mutations in the SPRED1 gene
    Marika Bianchi
    Veronica Saletti
    Roberto Micheli
    Silvia Esposito
    Anna Molinaro
    Stella Gagliardi
    Simona Orcesi
    Cristina Cereda
    Human Genome Variation, 2 (1)
  • [50] Two novel mutations in the CLCN1 gene of myotonia congenita
    Li, Gang
    NEUROLOGY, 2007, 68 (12) : A297 - A297